PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Bacterial toxin a potential trigger for multiple sclerosis

2014-01-29
(Press-News.org) Contact information: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Bacterial toxin a potential trigger for multiple sclerosis Researchers from Weill Cornell Medical College have added to the growing body of evidence that multiple sclerosis may be triggered by a toxin produced by common foodborne bacteria. The presented their research at the 2014 ASM Biodefense and Emerging Diseases Research Meeting.

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system characterized by blood brain (BBB) permeability and demyelination, a process in which the insulating myelin sheaths of neurons are damaged. The disease is thought to be triggered in a genetically susceptible individual by a combination of one or more environmental factors. The environmental trigger of MS, however, is still unknown. According to the National Multiple Sclerosis Society, the condition affects approximately 400,000 Americans and is, with the exception of trauma, the most frequent cause of neurological disability beginning in early to middle adulthood.

"We provide evidence that supports epsilon toxin's ability to cause BBB permeability and show that epsilon toxin kills the brain's myelin producing cells, oligodendrocytes; the same cells that die in MS lesions," says Jennifer Linden of Weill Cornell Medical College, who presented the research. "We also show that epsilon toxin targets other cells types associated with MS inflammation such as the retinal vascular and meningeal cells. Epsilon toxin may be responsible for triggering MS."

Epsilon toxin is produced by certain strains of Clostridium perfringens, a spore-forming bacterium that is one of the most common causes of foodborne illness in the United States. The U.S. Centers for Disease Control and Prevention estimates that non-epsilon toxin producing C. perfringens strains cause nearly a million cases of foodborne illness each year.

Previous studies have suggested that C. perfringens, and in particular epsilon toxin, may play a role in triggering MS. Late last year Linden and her colleagues discovered C. perfringens type B (a strain that is not known to infect humans and produces the epsilon toxin) in a 21-year-old woman who was experiencing a flare-up of her MS. To further test their hypothesis Linden and her colleagues studied the behavior of the toxin in mice, specifically which cells it targeted.

They discovered that the toxin did target the brain cells associated with MS pathology. But that was not all they found.

"Originally, we only thought that epsilon toxin would target the brain endothelium cells and oligodendrocytes; we just happened to notice that it also bound to and killed meningeal cells. This was exciting because it provides a possible explanation for meningeal inflammation and subpial cortical lesions exclusively observed in MS patients, but not fully understood," says Linden.

They also tested samples of local foods for the presence of C. perfringens and the toxin gene. Of the 37 food samples, 13.5% were positive for bacteria and 2.7% were positive for the epsilon toxin gene.

Linden says these findings are important, because if it can be confirmed that epsilon toxin is indeed a trigger of MS, development of a neutralizing antibody or vaccine directed against epsilon toxin might stop the progression of the disease or prevent it from even developing.

### The American Society for Microbiology (ASM) is the largest single life science society, composed of over 39,000 scientists and health professionals. Its mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.

More information on the ASM Biodefense and Emerging Diseases Research Meeting can be found online at http://www.asmbiodefense.org.


ELSE PRESS RELEASES FROM THIS DATE:

Intranasal vaccine protects mice against West Nile infection

2014-01-29
Researchers from Duke University have developed a nasal vaccine formulation that provides protective immunity against West Nile virus (WNV) infection in mice after only 2 doses. They present their ...

Finding points to possible new Parkinson's therapy

2014-01-29
A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease. ...

High-tech 'whole body' scan could improve treatment of bone marrow cancer

2014-01-29
The new type of magnetic resonance imaging (MRI) scan could improve care for a type of cancer called myeloma and reduce reliance on bone marrow biopsies, which can be painful for ...

Brain structure, function predict future memory performance in children, adolescents

2014-01-29
Washington, DC -- Assessing structural and functional changes in the brain may predict future ...

Protein modifies thyroid hormone levels according to body temperature

2014-01-29
The thyroid hormone thyroxine, which controls our day-to-day activity and was previously believed to remain at a constant level in the blood, actually fluctuates as a result of a protein ...

Parents less likely to spank after reading briefly about its links to problems in children

2014-01-29
Parents who spank their children ...

Researchers open door to new HIV therapy

2014-01-29
People infected with the Human Immunodeficiency Virus (HIV) can stave off the symptoms of AIDS thanks to drug cocktails that mainly target three enzymes ...

Study examines repeat colonoscopy in patients with polyps referred for surgery without biopsy-proven cancer

2014-01-29
DOWNERS GROVE, Ill. – January 28, 2014 – A new study reports that in the absence of biopsy-proven invasive cancer, a second colonoscopy ...

Skin cell response to environmental stimuli like viruses may predict type 1 diabetes

2014-01-29
(Boston)--Type 1 diabetes is a genetically-driven autoimmune disease of pancreatic beta-cells, whose origins remain unknown. Researchers at the Boston Medical Center ...

Churn Burn: Report outlines state strategies to assist with health insurance transitions

2014-01-29
PRINCETON, N.J.—A new culture of health care has been ushered in by the Patient Protection and Affordable Care Act ...

LAST 30 PRESS RELEASES:

PBM markets for Medicare Part D or Medicaid are highly concentrated in nearly every state

Baycrest study reveals how imagery styles shape pathways into STEM and why gender gaps persist

Decades later, brain training lowers dementia risk

Adrienne Sponberg named executive director of the Ecological Society of America

Cells in the ear that may be crucial for balance

Exploring why some children struggle to learn math

Math learning disability affects how the brain tackles problems, Stanford Medicine study shows

Dana-Farber research helps drive FDA label update for primary CNS lymphoma

Deep-sea microbes get unexpected energy boost

Coffee and tea intake, dementia risk, and cognitive function

Impact of a smartwatch hypertension notification feature for population screening

Glaciers in retreat: Uncovering tourism’s contradictions

Why melting glaciers are drawing more visitors and what that says about climate change

Mount Sinai scientists uncover link between influenza and heart disease

Study finds outdated Medicare rule delays nursing care, wastes hospital resources

Mortality among youth and young adults with autism spectrum disorder, intellectual disability, or cerebral palsy

Risk factors for the development of food allergy in infants and children

Organizational factors to reattract nurses to hospital employment

What drives food allergies? New study pinpoints early-life factors that raise risk

Early diagnosis key to improving childhood cancer survival

Microbiomes interconnect on a planetary-scale, new study finds

Let’s get on pancreatic cancer’s nerves

Intermittent fasting cut Crohn’s disease activity by 40% and halved inflammation in randomized clinical trial

New study in JNCCN unlocks important information about how to treat recurring prostate cancer

Simple at-home tests for detecting cat, dog viruses

New gut-brain discovery offers hope for treating ALS and dementia

Cognitive speed training linked to lower dementia incidence up to 20 years later

Businesses can either lead transformative change or risk extinction: IPBES

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

Dr. Paul Donlin-Asp of the University of Edinburgh to dissect the molecular functions and regulation of local SYNGAP1 protein synthesis with support from CURE SYNGAP1 (fka SynGAP Research Fund)

[Press-News.org] Bacterial toxin a potential trigger for multiple sclerosis